2 news items
Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
TPST
9 May 24
positive data from the Phase 1 Trial of TPST-1120 in patients with advanced solid tumors in the Journal of Cancer Research Communications
Tempest Announces Publication Of Data From Phase 1 Trial Of TPST-1120 In Patients With Advanced Solid Tumors In Journal Of Cancer Research Communications
TPST
4 Apr 24
to fight cancer, today announced that Cancer Research Communications published positive clinical data from the dose-escalation Phase 1 trial of TPST
- Prev
- 1
- Next